Stock Market

Investors remain puzzled due to persistent macro challenges, continued interest rate hikes, and the regional banking crisis. Given the ongoing uncertainties, sectors that are resilient during economic downturns could offer attractive investment opportunities. While not entirely immune to recessionary conditions, healthcare companies have the ability to navigate a tough macro backdrop due to the essential
0 Comments
Analysts love SoFi Technologies (NASDAQ:SOFI). I love it too, and even own some. SoFi can do everything from banking and brokerage to loans and crypto. A new unit of the company can service your mortgage. Software acquisitions means it offers these services retail and wholesale. SoFi can even run other banks’ computing systems. This is
0 Comments
To say the market for initial public offerings (IPOs) is in a funk would be a major understatement. In 2022, the worldwide IPO market went from record-breaking levels during the Covid-19 pandemic into a full-on depression, according to an analysis by EY. In 2022, there were 1,333 IPOs held, down 45% from 2021. Proceeds from
0 Comments
At first glance, the first-quarter 2023 results from electric vehicle (EV) manufacturer Tesla (NASDAQ:TSLA) don’t seem all that bad. However, many investors’ initial reaction was to sell TSLA stock. In the wake of this, opinions vary concerning the future trajectory of the Tesla share price. Fortunately, there is a dip-buying strategy that could work well
0 Comments
Is Wall Street’s opinion of Plug Power (NASDAQ:PLUG) optimistic or pessimistic? There’s an odd divergence between the ambitious consensus price target on PLUG stock and the multitude of downgrades. Still, hopefully, today we can wade through the sea of opinions and come to a conclusion about Plug Power. Plug Power is probably the most famous publicly
0 Comments
Investors have shown keen interest in biotech after Johnson & Johnson’s (NYSE:JNJ) impressive earnings beat that topped Wall Street’s expectations. The earnings beat reignited enthusiasm for biotech stocks, prompting investors to search for the next big players. The pharmaceutical giant’s adjusted earnings and revenue beat expectations, with strength reported in units including pharmaceuticals. J&J also
0 Comments